Navigation Links
Rat Study Sheds Light on Cocaine Addiction
Date:7/9/2010

FRIDAY, July 9 (HealthDay News) -- Researchers report that they've discovered tiny molecules that appear to forestall cocaine addiction in rats and may have the same effect in humans.

The findings, reported in the July 8 issue of the journal Nature, are preliminary, but they "offer promise for the development of a totally new class of anti-addiction medications," said study senior author Paul J. Kenny, an associate professor at Scripps Research Institute in Jupiter, Fla., in a news release from the U.S. National Institute on Drug Abuse (NIDA), which funded the study.

The molecules at issue, known as microRNAs, are a part of RNA and help the body follow the genetic instructions in DNA.

In the study, researchers gave cocaine to rats and discovered that it boosted levels of a specific sequence of microRNA in the brain. The rats disliked cocaine more as the levels went up, but liked it more as they went down.

"This study enhances our understanding of how brain mechanisms, at their most fundamental levels, may contribute to cocaine addiction vulnerability or resistance to it," Dr. Nora D. Volkow, NIDA director, said in the news release.

The findings may help explain why certain people become addicted to cocaine -- an estimated 15 percent of those who try it -- while most do not, the researchers noted.

At the moment, there's no anti-addiction drug to treat cocaine addicts, said addiction specialist Steven Shoptaw in an interview. But this research comes with a caveat, he added: cocaine addiction in rats fails "to fully account for the complexity of cocaine dependence in humans."

On the other hand, the findings "may be the first steps to describing the long sought-after 'switch'" that transforms cocaine use into cocaine addiction, said Shoptaw, a psychologist at the University of California at Los Angeles.

If the research does result in an anti-addiction drug, it will still be a challenge to convince people to use it, said addiction specialist Dr. Adam Bisaga, an associate professor of clinical psychiatry at Columbia University College of Physicians and Surgeons in New York City.

"Even if we have an effective medication, it needs to be a medication that patients are willing to take," Bisaga explained. "Some extremely effective treatments, such as Antabuse for alcohol dependence, are underutilized because these medications require a lot of effort on the part of the doctor to work with patients to accept this treatment."

More information

For more about cocaine, visit the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCES: U.S. National Institute on Drug Abuse, news release, July 7, 2010; Steven Shoptaw, Ph.D., professor, University of California at Los Angeles; Adam Bisaga, M.D., associate professor of clinical psychiatry, Columbia University College of Physicians and Surgeons, New York City


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study: Medicare policy may account for growing length of hospice stays in nursing homes
2. Study Suggests Link Between HPV, Skin Cancer
3. Drug study shows improvement in major orthopedic surgery care
4. Study suggests link between scleroderma, cancer in certain patients
5. Fish Oil Supplements Linked to Lower Risk of Breast Cancer: Study
6. Study finds patients benefit from thorough discussion of recommended operations
7. Many Docs Deliver Cancer Diagnosis Badly: Study
8. Study: Higher-protein diets support weight loss, but may lower bone density in postmenopausal women
9. Legalizing marijuana in California would lower the price of the drug and increase use, study finds
10. Study shows race, not experience, impacts hiring in sports world
11. 1 in 4 Californian children have never seen a dentist, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Rat Study Sheds Light on Cocaine Addiction
(Date:1/24/2017)... ... January 23, 2017 , ... The January 2017 issue of the ... study on how outdoor behavioral healthcare (OBH) – also known as wilderness therapy – ... while experiencing an increased sense of purpose both during and after treatment. , ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... a new plugin that allows sleep centers to automatically connect and initialize all ... a thin client browser plugin is quickly installed on first use and then ...
(Date:1/23/2017)... Alto, CA (PRWEB) , ... ... ... a provider of translation and localization services for life science companies, has ... and inspection organization, TÜV SÜD America. ISO 17100 is the globally recognized ...
(Date:1/23/2017)... ... 23, 2017 , ... Wooden and plastic balance boards have been around since at least the ... Board is the first and only balance board to use a patent-pending design featuring ... at the same time as well as skill-level adjustable for all ages and abilities. ...
(Date:1/23/2017)... Indiana (PRWEB) , ... January 23, 2017 , ... ... Center for Assisted Living (IHCA/INCAL), will serve as a healthcare industry expert at ... 23. The panel discussion, moderated by Inside Indiana Business host Gerry Dick, will ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Stock-Callers.com today presents the following Generic ... CPRX ), Sophiris Bio Inc. (NASDAQ: SPHS ), ... Therapeutics Inc. (NASDAQ: AGRX ). These companies are ... late trade on Friday, January 20 th , 2017, with ... of health care companies in the S&P 500 also were ...
(Date:1/23/2017)... , January 23, 2017 The global  anxiety disorders and ... by 2025. The rising incidence of depression worldwide is anticipated to drive the ... resulted in the declining demand for antidepressants in the recent years. ... ... Grand View Research Logo ...
(Date:1/23/2017)... DIEGO and PALMA, Spain ... Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company ... that the first patient has been enrolled in ... lead candidate, SNF472, for the treatment of cardiovascular ... (HD). Most ESRD patients, in the ...
Breaking Medicine Technology: